Oleate salt formation and mesomorphic behavior in the propranolol/oleic acid binary system

Journal of Pharmaceutical Sciences

Volumn 88, Issue 6, 1999, Pages 586-591

  Crowley, Kieran J ^a   Forbes, Robert T ^a   York, Peter ^a   Nyqvist, Håkan ^b   Camber, Ola ^b  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b Astra Arcus AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

OLEIC ACID; PROPRANOLOL;

ARTICLE; COMPLEX FORMATION; DRUG DELIVERY SYSTEM; INFRARED SPECTROSCOPY; MOLECULAR DYNAMICS; PHASE TRANSITION; PHYSICAL CHEMISTRY; THERMAL ANALYSIS; X RAY CRYSTALLOGRAPHY;

EID: 0033014204     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js9804967     Document Type: Article

References (24)

1. Charman, W. N.; Porter, C. J. H.; Mithani, S.; Dressman, J. B. Physicochemical and physiological mechanisms for the effects of food on drug absorption. J. Pharm. Sci. 1897, 86, 269-281.
2. Brown, N. J.; Read, N. W.; Richardson, A.; Rumsey, R. D. E.; Bogentoft, C. Characteristics of lipid substances activating the ileal brake in the rat. Gut 1990, 31, 1126-1129.
3. Muranishi, S. Modification of intestinal absorption of drugs by lipoidal adjuvants. Pharm. Res. 1985, 2, 108-118.
4. Charman, W. N.; Stella, V. J. Transport of lipophilic molecules by the intestinal lymphatic system. Adv. Drug Del. Rev. 1991, 7, 1-14.
5. Barnwell, S. G.; Burns, S. J.; Higginbottom, S.; Whelan, I.; Corness, D.; Hay, G.; Rosenberg, E.; Attwood, D. Demonstration of the importance of biphasic oleic acid delivery for enhancing the bioavailability of propranolol in healthy volunteers. Int. J. Pharm. 1996, 128, 145-154.
6. Riddell, J. G.; Harron, D. W. G.; Shanks, R. G. Clinical pharmacokinetics of β-adrenoceptor antagonists. Clin. Pharmacokin. 1987, 12, 305-320.
7. White, D. G.; Story, M. J.; Barnwell, S. G. An experimental animal model for studying the effects of a novel lymphatic drug delivery system for propranolol. Int. J. Pharm. 1991, 69, 169-174.
8. Small, D. M., Ed. Handbook of Lipid Reseach 4. The Physical Chemistry of Lipids; Plenum Press: New York, 1988.
9. Kobayashi, M.; Kaneko, F.; Sato, K.; Suzuki, M. Vibrational spectroscopic study on polymorphism and order-disorder phase transition in oleic acid. J. Phys. Chem. 1986, 90, 6371-6378.
10. Leadbetter, A. J. Structural classification of liquid crystals. In Thermotropic Liquid Crystals; Gray, G. W., Ed.; J. Wiley and Sons: U.K., 1987; pp 1-27.
11. Neau, S. H.; Shinwari, M. K.; Hellmuth, E. W. Melting point phase diagrams of free base and hydrochloride salts of bevantolol, pindolol and propranolol. Int. J. Pharm. 1993, 99, 303-310.
12. Ford, J. L.; Timmins, P. Pharmaceutical Thermal Analysis: Techniques and Applications; Ellis Horwood: Chichester, U.K., 1989.
13. Atkins, P. W., Ed. Physical Chemistry, 6th ed.; Oxford University Press: U.K., 1998.
14. Cheda, J. A. R.; Ortega, F.; Sanchez-Arenas, A.; Cosio, A.; Fernandez-Garcia, M.; Fernandez-Martin, F.; Roux, M. V.; Turrion, C. Binary phase diagrams of lead(II) n-alkanoates and n-alkanoic acids. Pure Appl. Chem. 1992, 64, 65-71.
15. Ogiso, T.; Shintani, M. Mechanism for the enhancement effect of fatty acids on the percutaneous absorption of propranolol. J. Pharm. Sci. 1990, 79, 1065-1071.
16. Crowley, K. J. Unpublished results.
17. Harwood, J. L.; Padley, F. B. X-ray diffraction. In The Lipid Handbook, 2nd ed.; Gunstone, F. D., Harwood, J. L., Padley, F. B., Eds.; Chapman and Hall: London, 1994; pp 538-539.
18. Suzuki, M.; Ogaki, T. Crystallization and transformation mechanisms of α-, β-, and γ-polymorphs of ultrapure oleic acid. J. Am. Oil Chem. Soc. 1985, 62, 1600-1604.
19. McKie, D.; McKie, C. Crystalline solids; Nelson: Walton-on-Thames, U.K., 1980; pp 506-557.
20. El-Banna, H. M.; El-Gholmy, Z. A.; Hammouda, Y. Phase diagram and dissolution rate studies on hydrochlorothiazide-urea solid dispersions. Pharm. Acta Helv. 1980, 55, 244-248.
21. Grant, D. J. W.; Jacobson, H.; Fairbrother, J. E.; Patel, C. G. Phases in the paracetamol-phenazone system. Int. J. Pharm. 1980, 5, 109-116.
22. Winfield, A. J.; Al Saidan, S. M. H. Compound formation in phenobarbitone-urea systems. Int. J. Pharm. 1981, 8, 211-216.
23. Aungst, B. J.; Hussain, M. A. Sustained propranolol delivery and increased oral bioavailability in dogs given a propranolol laurate salt. Pharm. Res. 1992, 9, 1507-1509.
24. Hussain, A.; Hirai, S.; Bawarshi, R. Nasal absorption of propranolol from different dosage forms by rats and dogs. J. Pharm. Sci. 1980, 69, 1411-1413.